LENZ Therapeutics announces reorganization to cut 2027 operating expenses by over 50% to about $70M-$75M

LENZ Therapeutics announced a reorganization to cut 2027 operating expenses by over 50% to about $70M-$75M, excluding stock-based compensation.

Detected & updated continuously · Source: Nebula